Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30859244

CC(C)[C@H](NC(=O)[C@@H]1CCCN1Cc1ccccc1)C(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ELANE P08246 7/20 0.50
PTGER4 P35408 1/20 0.50
CTSG P08311 1/20 0.49
NPSR1 Q6W5P4 1/20 0.48
KMT2A Q03164 1/20 0.48
CNR2 P34972 1/20 0.46
CMA1 P23946 6/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CCR4 P51679 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL29290360 0.79 CYP1A2 (0.53) NPSR1CNR2CYP2C19SMN1; SMN2CCR4
Trifluoroacetic Acid SCHEMBL4829974 0.77 PTGER4 (0.50) PTGER4CNR2
SCHEMBL10154052 0.76 NPSR1 (0.65) NPSR1KMT2ACNR2SMN1; SMN2CCR4
SCHEMBL14242685 0.76 SPHK1 (0.54) NPSR1KMT2ACNR2CYP2C19SMN1; SMN2
SCHEMBL26999849 0.76 KMT2A (0.48) ELANEKMT2ASMN1; SMN2
SCHEMBL29641544 0.75 OPRM1 (0.56) ELANECTSG
SCHEMBL30440339 0.75 OPRM1 (0.56) ELANECTSG
Trifluoroacetic Acid SCHEMBL4372725 0.74 NPSR1 (0.48) PTGER4NPSR1CNR2CCR4
Trifluoroacetic Acid SCHEMBL4376570 0.74 NPSR1 (0.48) PTGER4NPSR1CNR2CCR4
SCHEMBL7315812 0.74 CTRB1 (0.67) ELANENPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619037-A1 SMALL MOLECULE-DRUG-CONJUGATES CLEAVABLE IN A TUMOR MICROENVIRONMENT Lerchen, Hans-Georg (DE) 2025-09-24 EP disclosed
WO-2024105197-A1 SMALL MOLECULE-DRUG-CONJUGATES CLEAVABLE IN A TUMOR MICROENVIRONMENT VINCERX PHARMA GMBH (DE) 2024-05-23 WO disclosed